Press Releases
Washington Business Journal
Washington Business Journal Exclusive: Bethesda biotech switches gears to develop COVID-19 treatment
March, 2020: PepVax is developing an immunotherapy, to both help patients suffering from the illness and protect healthy people from contracting it...Read more
STATNews
First Opinion by Mahesh Narayanan: Trump’s trade war is hurting companies like mine — and the biotechnology industry
September, 2019: PepVax has developed SMARTmid, a “Trojan Horse” drug delivery platform for DNA and RNA based treatments...Read more
BioPharma-Reporter
BioPharma-Reporter: PepVax creates 'Trojan Horse' drug delivery platform
August, 2018: PepVax has developed SMARTmid, a “Trojan Horse” drug delivery platform for DNA and RNA based treatments...Read more
Washington Business Journal
Washington Business Journal: This Bethesda biotech wants to help other biotechs get drugs to patients faster
August, 2018: Five years after opening a $50,000 crowdfunding campaign for his biotech, Mahesh Narayanan has launched the drug delivery platform it was intended to fund...Read more
Business Insider Press Release
Business Insider Press Release: PepVax Announces Completion of Efficacy Study with Key Pre-Clinical Data to Validate PVX-009, Addition to its Advisory Board and Other Updates
January, 2018: PepVax, Inc., an early-stage biotechnology company, announced today that it has successfully completed the efficacy study for its lead candidate, PVX-009....Read more
Business Insider Press Release
Business Insider Press Release: PepVax, Inc. Wins “Best in Show” at Philadelphia 1st Pitch Life Science Competition
October, 2017: Mid-Atlantic Bio Angels (MABA) announces today that PepVax, Inc. (http://www.pepvax.co), which is developing a therapeutic treatment against triple negative breast cancer (TNBC), was named “Best in Show”...Read more
Yahoo Press Release
Yahoo Press Release: PepVax begins efficacy study for lead candidate
August, 2017: PepVax, Inc., an early-stage biotechnology company, announced today that it has initiated its in vivo efficacy study for lead candidate, PVX-009...Read more
Yahoo Press Release
Yahoo Press Release: New Milestones and Upcoming Events for PepVax
July, 2017: PepVax, Inc., an early stage biotechnology company developing an immunotherapy treatment for triple-negative breast cancer (TNBC), today announced several new milestones and upcoming events that demonstrate the company's continued growth...Read more
TEDCO Press Release
TEDCO Press Release: Maryland Entrepreneur Resource List Success Story
The Maryland Entrepreneurs Resource List (MERL) started in 2012 and has had some recent success in providing leadership to early stage companies. One example is Ocular Proteomics, LLC, OPL. Joshua Hines, business director for OPL, has contacted several MERL...Read more
Washington Business Journal
Washington Business Journal: Can Indiegogo fund biotech? PepVax bets on it
Biotech and crowdfunding don't sound particularly compatible. The staggering research, clinical and regulatory costs associated with putting "pill number one" on the market seems like it would prevent a Kickstarter or Indiegogo campaign, especially since trading equity for funding isn't legal yet... Read more
Publications
Journal of Human Genetics and Genomic Medicine
Genetic Association between HERV-H LTR Associating 2 (HHLA2) Protein and MAGE-B5 Variant in Viral Related Diseases.
Achinko DA, Narayanan M, Norman EF, Anton Dormer (2020) Genetic Association between HERV-H LTR Associating 2 (HHLA2) Protein and MAGE-B5 Variant in Viral Related Diseases. J Hum Genet Genomic Med 1: 105...Read more
F1000 Research Publication
Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease
June, 2015: Paper published by PepVax describing the Epitope specificity and protein signaling interactions driving epidemic occurrences of Ebola disease. Ebolavirus has as main hosts, humans and nonhuman primates where its pathogenic effects result to serious hemorrhagic fever with lethal...Read more
Online Journal of Bioinformatics
A novel strategy of In silico peptide vaccine design for Streptococcus mutans.
August, 2014: Paper published by PepVax describing a novel strategy of In silico peptide vaccine design for Streptococcus mutans. Several attempts have been made towards the development of a viable vaccine for Streptococcus mutans (S. Mutans). This Gram positive bacterium is...Read more